GlassScriptPhysician profile
Stephen H Livingston
NPI 1245295419
$1,013.30
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $433 · 2020: $99.36 · 2021: $171 · 2022: $114 · 2023: $177 · 2024: $18.95.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $99.99 · Food and Beverage: $95.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $99.99 |
| Food and Beverage | $95.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $196.77 | 2019-2024 | |
| Astellas Pharma US INC | $117.21 | 2019-2023 | |
| Therapeuticsmd, INC. | $83.09 | 2019-2020 | |
| Pfizer INC. | $80.80 | 2019-2021 | |
| Exeltis, USA INC. | $69.45 | 2019-2021 | |
| Duchesnay USA Incorporated | $62.53 | 2019 | |
| Mycovia Pharmaceuticals, INC. | $41.38 | 2023 | Vivjoa |
| Merck Sharp & Dohme LLC | $38.84 | 2019 | |
| Exact Sciences Corporation | $35.38 | 2023 | Cologuard Collection Kit |
| Covidien LP | $33.03 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $31.19 | 2019-2021 | |
| Scynexis, INC. | $21.53 | 2022 | |
| Evofem Biosciences, INC. | $19.39 | 2021 | |
| Mallinckrodt Enterprises LLC | $18.88 | 2019 | |
| Agile Therapeutics, INC. | $17.69 | 2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vivus LLC | $17.67 | 2019 | |
| Amag Pharmaceuticals, INC. | $16.77 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $16.58 | 2019 | |
| Mylan Pharmaceuticals INC. | $14.49 | 2021 | |
| Lupin INC. | $14.41 | 2020 | |
| Avion Pharmaceuticals | $13.54 | 2022 | |
| Millicent US INC | $13.53 | 2019 | |
| Novo Nordisk INC | $13.39 | 2019 | |
| Aspira Women'S Health INC | $13.29 | 2020 | |
| Coopersurgical, INC. | $12.47 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Livingston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.